Lab21 is a global provider of state-of-the-art diagnostic products and services, supporting healthcare and environmental markets. Established in 2005 with the vision of providing 21st century diagnostics the Company’s main objective is to protect the health of people and the environment. We believe that ‘prevention is better than cure’ and we aim to provide information that helps to protect from the health problems of tomorrow.

www.lab21.com

Myconostica

Myconostica Ltd develops and supplies molecular diagnostic products to aid rapid andaccurate diagnosis of life-threatening invasive fungal infections.

Traditional methods for the detection of fungal pathogens, such as culture and microscopy, are well-documented as being relatively insensitive and slow. Myconostica will use advances in molecular techniques, such as Real-Time PCR, to develop a range of assays for the rapid, accurate and sensitive detection of fungi such as Aspergillus spp., Pneumocystis jirovecii and Candida spp.

www.myconostica.co.uk